Metis Global Partners LLC Buys Shares of 12,723 Amrize Ltd $AMRZ

Metis Global Partners LLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZ) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 12,723 shares of the company’s stock, valued at approximately $635,000.

A number of other hedge funds have also added to or reduced their stakes in the company. Credit Industriel ET Commercial bought a new stake in Amrize during the second quarter worth $109,000. Private Capital Advisors Inc. acquired a new position in shares of Amrize during the 2nd quarter worth $233,000. Cullen Frost Bankers Inc. bought a new stake in shares of Amrize during the 2nd quarter worth $244,000. Virtus Family Office LLC acquired a new stake in Amrize in the second quarter valued at about $253,000. Finally, swisspartners Advisors Ltd acquired a new stake in Amrize in the second quarter valued at about $324,000.

Insider Activity

In other news, CEO Jan Philipp Jenisch purchased 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were acquired at an average price of $52.64 per share, with a total value of $2,895,200.00. Following the completion of the transaction, the chief executive officer owned 1,505,000 shares of the company’s stock, valued at $79,223,200. The trade was a 3.79% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stephen S. Clark acquired 5,000 shares of the stock in a transaction dated Friday, August 15th. The stock was acquired at an average cost of $51.82 per share, with a total value of $259,100.00. Following the completion of the transaction, the insider owned 5,000 shares in the company, valued at approximately $259,100. This represents a ? increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 74,500 shares of company stock worth $3,900,655.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Wall Street Zen raised shares of Amrize to a “hold” rating in a report on Saturday, October 25th. Barclays assumed coverage on shares of Amrize in a research report on Tuesday, October 7th. They set an “equal weight” rating for the company. Citigroup raised their target price on shares of Amrize from $60.00 to $63.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. Oddo Bhf started coverage on shares of Amrize in a report on Monday, November 3rd. They set a “neutral” rating for the company. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amrize in a report on Thursday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $58.71.

Amrize Stock Up 0.6%

Shares of NYSE:AMRZ opened at $50.03 on Thursday. The company has a market cap of $27.67 billion and a price-to-earnings ratio of 27.19. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $56.29. The stock’s fifty day moving average is $50.30. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company’s quarterly revenue was up 6.6% compared to the same quarter last year.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.